The content on this site is intended for healthcare professionals only
Second generation TKIs in chronic myeloid leukaemia
Reducing global cancer mortality
New findings in proteasome inhibitors for myeloma patients
Treatment of multiple myeloma at the Dana Faber Institute
International Myeloma Workshop 2011 round up
Changing dynamics of elderly myeloma patients
Disease staging in myeloma and the implications for therapy
Techniques to assess response to treatment and the management of bone disease in myeloma
Multiple Myeloma in the transplant setting (2/2)
Multiple Myeloma in the non-transplant setting (1/2)
International Myeloma Workshop highlights and ongoing IMF studies
Lenalidomide and dexamethasone to delay progression of smouldering multiple myeloma
